文献速递冠心病血脂与心血管预防

已知冠心病的最佳药物治疗综述

Optimal Medical Therapy for Known Coronary Artery Disease: A Review.
PubMed 文献 · JAMA Cardiol · 2017-01-01

本综述探讨已知冠心病患者的最佳药物治疗(OMT)现状,该疗法被指南推荐用于二级预防。来自广泛患者群体、当代随机试验及近期药房记录研究的证据表明,OMT的实施远未理想。作者建议通过更好患者教育、增加提高依从性的干预措施及门诊长期OMT绩效指标来改善质量。

要点

  • OMT可有效预防冠心病患者复发事件,获指南推荐。
  • 现有证据显示OMT的实际实施情况远未达到理想水平。
  • 改善OMT实施或有助于降低美国心脏病死亡率。

核心结论

  • 改善冠心病患者OMT的实施可能有助于降低美国近期报告的心脏病死亡率上升。

研究设计与样本

  • 本综述检索并汇总了广泛患者群体、当代随机试验及多项近期药房记录研究等证据。

主要发现

  • 来自广泛患者群体、当代随机试验和多项近期药房记录研究的证据表明,OMT的实施远未理想。

临床怎么用

  • 建议通过更好的患者教育、增加已知能提高依从性的干预措施,以及使用关注门诊长期OMT的绩效指标来改善质量。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: This review examines the current state-of-the-art optimal medical therapy (OMT) for patients with known coronary artery disease. This therapy, which is sometimes labeled as secondary prevention, is effective in preventing recurrent events and is recommended by the American College of Cardiology Foundation/American Heart Association guidelines. Optimal medical therapy is of recognized public health benefit. OBSERVATIONS: The available evidence from broad patient populations, contemporary randomized trials, and multiple recent studies with pharmacy records indicates that the delivery of OMT is far from ideal. We suggest approaches for quality improvement, including better patient education, the increased use of interventions that are known to improve compliance, and the use of performance measures focused on long-term OMT in outpatient care. CONCLUSIONS AND RELEVANCE: Improvement in the delivery of OMT to patients with coronary artery disease is one possible step to help the United States reduce the recently reported increase in death rate from heart disease.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Gibbons RJ, Miller TD. Optimal Medical Therapy for Known Coronary Artery Disease: A Review. JAMA Cardiol. 2017. PMID: 28700788. doi:10.1001/jamacardio.2017.2249

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。